There is a general deficit in France for the financing of scale-ups, highlighted in particular by the Tibi report in 2019. This is particularly the case in healthcare, where SMEs encounter financing problems in the more advanced stages of their development.

According to federations and company support networks, investors in France are not sufficiently familiar with the healthtech sector and its business models (length of clinical trials, complexity of market access), whereas in English-speaking countries, investors are quicker to take a position but are often required to invest in the investor's country of origin.

This proposal aims to objectify the capital financing issues for companies in the healthtech, and particularly in eHealth, in order to implement measures to facilitate access to French capital for these companies during their growth.
In order to provide a more solid basis for healthtech start-ups in France to scale up and help them go international, the measure proposes to strengthen the French supply of late-stage funds dedicated to healthtech.
This action will take the form of a broad consultation of the healthcare equity ecosystem and may lead to:

• Encouraging health industry to invest in the late stage
• Raising awareness of health issues among institutions already participating in the Tibi system